drugset / Trial / NCT01448070
Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to show that the product of the new production process has a similar pharmacological profile to the traditional process used for the current commercial product Actrapid®.
Timeline
- Start
- 2002-10-15
- Primary completion
- 2002-12-20
- Completion
- 2002-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 0.2 iu/kg | Subcutaneous |